The authors concluded that probiotics may improve symptoms in patients with irritable bowel syndrome, but that benefits were uncertain and further research was required. The authors' cautious conclusion appeared to reflect the evidence presented, but the limited search, lack of reporting of review methods and an incomplete validity assessment made it difficult to comment on reliability.
The included studies evaluated a variety of different probiotics (details were reported). Where reported, patients included people with Rome I and II criteria, Manning criteria, diarrhoea-predominant irritable bowel syndrome and constipation-predominant irritable bowel syndrome. Most patients in most studies were female (range 60 to 100per cent). In most studies the mean age ranged from 40 to 49 years; in one study patients were aged 25 to 70 years. Studies used different methods to assess outcomes; symptom scores were measured subjectively by patients or clinicians. In most studies, the duration of treatment was eight weeks or less.
The authors stated neither how papers were selected for the review nor how many reviewers performed the selection.
Assessment of study quality
Only blinded RCTs were included. The authors did not state that they assessed any other aspect of validity.
Data extraction
The authors stated neither how data were extracted for the review nor how many reviewers performed the data extraction. For each study, the level of statistical significance was presented for reported outcomes.
Methods of synthesis
The studies were grouped by outcome and combined in a narrative synthesis. Details were also presented in tables.
Results of the review
Fourteen RCTs were included (n=1,258). Sample size ranged from 12 to 362.
Significant improvements were reported for probiotic groups compared to placebo in seven of 11 studies that assessed global symptoms, five of eight studies that assessed abdominal pain or distension and four of five studies that assessed flatulence. Results from four studies that assessed transit time or bowel habits were mixed.
Authors' conclusions
Probiotics may improve symptoms in patients with irritable bowel syndrome, but benefits were unclear and further research was required.
